Wallin, Chela M <br/><br/>
Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model.  [electronic resource] 

 -  Drug and alcohol dependence  12 2019 
 - 107625 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0046 
<br/><br/><label>Standard No.: </label>10.1016/j.drugalcdep.2019.107625  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Analgesics, Opioid--therapeutic use<br/>Animals<br/>Animals, Newborn--growth & development<br/>Behavior, Animal--drug effects<br/>Buprenorphine--adverse effects<br/>Dose-Response Relationship, Drug<br/>Female<br/>Male<br/>Maternal Behavior--drug effects<br/>Narcotic Antagonists--adverse effects<br/>Neonatal Abstinence Syndrome--etiology<br/>Opioid-Related Disorders--drug therapy<br/>Pregnancy<br/>Prenatal Exposure Delayed Effects--etiology<br/>Rats<br/>Substance Withdrawal Syndrome--drug therapy